Tandem diabetes care, inc. (TNDM)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Operating Activities
Net loss

-24,800

-122,611

-73,033

-83,447

-72,418

-79,524

-63,139

-33,015

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

6,072

5,821

6,866

5,489

4,829

4,389

3,167

2,032

Accretion of discount on notes payable and convertible notes

-

-

-

-

-

-

-

1,209

Interest expense related to amortization of debt discount and debt issuance costs

0

1,721

1,883

274

138

219

595

836

Payment in kind interest accrual of notes payable

0

0

1,657

927

153

-

-

-

Provision for Doubtful Accounts

2,322

1,448

824

632

70

188

275

46

Provision (benefit) for inventory obsolescence

2,353

607

26

3,343

404

163

815

335

Change in fair value of common stock warrants

11,075

66,494

-1,021

-

-

-

9,002

-2,556

Amortization of discount on short-term investments

565

-539

16

85

-4

53

-

-

Stock-based compensation expense

58,071

23,736

12,628

11,660

13,096

14,995

4,456

246

Gain (Loss) on Extinguishment of Debt

0

-5,313

0

-

-

-

-

-2,770

Other

-321

152

159

-78

-76

41

87

57

Changes in operating assets and liabilities:
Accounts receivable, net

13,698

15,848

10,445

-2,251

6,473

2,541

3,161

2,458

Inventories, net

30,975

-6,756

5,894

6,904

6,084

1,820

4,625

6,596

Prepaid and other current assets

584

1,576

-1,831

2,466

395

82

-106

1,054

Other long-term assets

580

26

-4

2

-131

150

85

-

Accounts payable

8,910

1,641

-1,953

3,234

3,355

-1,225

859

1,383

Accrued expenses

4,076

1,097

1,203

-497

-734

973

342

918

Employee-related liabilities

4,285

9,542

3,873

-1,578

2,039

3,846

3,885

979

Deferred revenue

4,589

2,074

-3,906

4,610

981

429

-1,472

1,884

Other current liabilities

4,216

2,434

-432

573

1,924

-1,575

895

2,342

Deferred rent

-

-

-

1

-631

-461

-522

-234

Other long-term liabilities

7,412

2,367

-390

890

923

810

763

-

Payments received on note receivable from employees

-

-

-

-

-

-

-

175

Net cash used in operating activities

41,905

-8,319

-66,136

-61,173

-58,764

-61,378

-47,757

-33,471

Investing Activities
Purchases of short-term investments

164,572

123,553

0

30,622

80,191

67,101

5,095

-

Proceeds from maturities of short-term investments

114,908

35,800

8,500

-

-

-

-

-

Proceeds from sales of short-term investments

12,250

0

0

50,000

88,450

36,210

-

-

Purchases of property and equipment

19,541

2,986

5,718

8,930

5,764

4,406

4,010

4,529

Purchase of patents

-

-

-

-

74

173

2,000

1,000

Issuance of convertible notes payable

-

-

-

-

-

-

-

12,208

Net cash provided by investing activities

-56,955

-90,739

2,782

10,448

2,421

-35,470

-11,105

-5,529

Financing Activities
Proceeds from exercise of common stock warrants

327

29,575

0

-

-

-

-

-

Issuance of notes payable, net of issuance costs

-

-

-

49,994

-

29,925

28,874

5,000

Restricted cash in connection with notes payable

-

-

-

-

-

-50

2,000

-

Principal payments on notes payable

0

87,711

0

-

-

30,000

4,396

604

Proceeds from issuance of preferred stock for cash, net of offering costs

-

-

-

-

-

-

15,991

30,867

Proceeds from public offerings, net of offering costs

0

172,929

39,806

-

64,862

-

125,040

-

Proceeds from issuance of common stock under Company stock plans

23,880

2,391

570

2,321

3,393

3,664

2,575

35

Net cash provided by financing activities

24,207

117,184

40,376

52,315

68,255

3,639

166,084

47,506

Effect of foreign exchange rate changes on cash

191

0

0

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

9,348

18,126

-22,978

1,590

11,912

-93,209

107,222

8,506

Supplemental disclosures of cash flow information
Interest paid

0

10,805

7,876

4,401

3,345

3,369

4,115

297

Income taxes paid

67

16

22

23

9

71

19

3

Supplemental schedule of non-cash investing and financing activities
Right-of-use assets obtained in exchange for operating lease obligations

11,635

0

0

-

-

-

-

-

Lease incentive - lessor-paid tenant improvements

0

13

3,292

-

933

1,604

-

2,018

Common and preferred stock warrants issued, including incremental value of modification of warrants

-

-

-

-

-

-

437

3,815

Debt discount included in other long-term liabilities

0

0

4,137

1,509

-

-

-

-

Common stock warrants issued in connection with term loan

0

0

3,331

-

-

-

-

-

Unsettled purchase of investments classified as cash equivalents in other current liabilities

0

1,708

0

-

-

-

-

-

Patent included in accrued expense

-

-

-

-

-

74

-

-

Property and equipment included in accounts payable

2,134

125

92

501

1,457

789

-

200

Conversion of preferred stock warrants into common stock warrants

-

-

-

-

-

-

9,550

-

Conversion of convertible preferred stock into common stock

-

-

-

-

-

-

144,258

-